Related Experiment Video
Updated: Feb 26, 2026

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
Disparities in testing for latent tuberculosis infection in a large US integrated healthcare system
Jennifer H Ku1, Parag Mahale2, Lei Qian2
1Center for Integrated Health Care Research, Kaiser Permanente Hawaii, Honolulu, HI, USA.
Objectives:
Disparities in latent tuberculosis infection (LTBI) testing by birth country and socioeconomic status (SES) are not well understood. We used electronic health records from Kaiser Permanente Southern California (2010-2019) to examine disparities in LTBI testing across SES among those born in high-vs. low-tuberculosis (TB) incidence countries.
Study Design:
Retrospective cohort study.
Methods:
We examined LTBI testing rates and measures of disparities (absolute/relative concentration index, between-group variance, and mean log deviation) across area-level SES and racial/ethnic groups, by birth in a high-vs. low-TB incidence country, with imputed data for missing birth country.
Results:
We included 1,740,428 individuals, with a median age of 37.0 years (interquartile range 27.0, 51.0), who were 50.3% female (n = 875,879), and 39.2% Hispanic (n = 682,870); 1,205,853 (69.3%) were born in a country with low TB incidence. Among adults born in low-TB incidence countries (n = 1,205,853; 315.3 tests/10,000 person-years), testing rates remained stable (annual percent change [APC] = -0.69% [95% CI: -1.55, 0.41]). Among adults born in high-TB incidence countries (n = 534,575; 246.7 tests/10,000 person-years), testing rates increased over time (APC = 1.90% [1.14, 2.90]) with a higher rate of increase for those with higher SES. Among individuals born in a high-TB incidence country, disparities by SES and racial/ethnic groups increased over time.
Conclusions:
Disparities in LTBI testing in individuals born in high-vs. low-TB incidence countries decreased overall, but increased disproportionally in those with higher SES among those born in high-TB incidence countries. Continued research is needed to understand the causes of disparities, and to inform interventions to reduce disparities.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...

